Vbi Vaccines Stock Investor Sentiment

VBIV Stock  USD 0.61  0.01  1.67%   
Slightly above 55% of VBI Vaccines' sophisticated investors are presently thinking to get in. The analysis of the overall investor sentiment regarding VBI Vaccines suggests that some traders are interested. VBI Vaccines' investor sentiment overview provides quick insight into current market opportunities from investing in VBI Vaccines. The current market sentiment, together with VBI Vaccines' historical and current headlines, can help investors time the market. In addition, many technical investors use VBI Vaccines stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
VBI Vaccines stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of VBI daily returns and investor perception about the current price of VBI Vaccines as well as its diversification or hedging effects on your existing portfolios.
  

VBI Vaccines Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards VBI Vaccines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at finance.yahoo.com         
Vaccines Market Worth 94.9 billion MarketsandMarkets
Yahoo News
over a week ago at news.google.com         
Individual investors account for 55 percent of VBI Vaccines Inc.s ownership, while private equity fi...
Google News at Macroaxis
over a week ago at businesswire.com         
VBI Vaccines Reports Full Year 2023 Financial Results
businesswire News
over a week ago at seekingalpha.com         
VBI Vaccines FY Non-GAAP EPS of 3.96
seekingalpha News
over a week ago at investorplace.com         
VBIV Stock Earnings VBI Vaccines Beats EPS, Misses Revenue for Q4 2023
sbwire news
over a week ago at businesswire.com         
VBI Vaccines Announces Closing of 2 Million Registered Direct Offering Priced At-the-Market Under Na...
businesswire News
over a week ago at businesswire.com         
VBI Vaccines Announces Closing of 2 Million Registered Direct Offering Priced At-the-Market Under Na...
businesswire News
over a week ago at businesswire.com         
VBI Vaccines Announces Closing of 2 Million Registered Direct Offering Priced At-the-Market Under Na...
businesswire News
over a week ago at businesswire.com         
VBI Vaccines Announces Closing of 2 Million Registered Direct Offering Priced At-the-Market Under Na...
businesswire News
over a week ago at finance.yahoo.com         
VBI Vaccines Announces Closing of 2 Million Registered Direct Offering Priced At-the-Market Under Na...
Yahoo News
over two weeks ago at businesswire.com         
VBI Vaccines Announces 2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
businesswire News
over two weeks ago at investing.com         
VBI Vaccines secures 2 million in direct offering
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
VBI Vaccines Announces 2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Yahoo News
over two weeks ago at businesswire.com         
VBI Vaccines Announces 2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
businesswire News
over two weeks ago at businesswire.com         
VBI Vaccines Announces 2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
businesswire News
Far too much social signal, news, headlines, and media speculation about VBI Vaccines that are available to investors today. That information is available publicly through VBI media outlets and privately through word of mouth or via VBI internal channels. However, regardless of the origin, that massive amount of VBI data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of VBI Vaccines news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of VBI Vaccines relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to VBI Vaccines' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive VBI Vaccines alpha.

VBI Vaccines Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
North Carolina biotech inks 30M deal to expand its global pipeline
02/15/2024
2
VBI Vaccines Inc at H C Wainwright Hepatitis B Virus Virtual Conference Transcript
03/05/2024
3
Canada funds VBI Vaccines novel vaccine technology development
04/02/2024
4
VBI Vaccines Announces 2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
04/09/2024
5
VBI Vaccines Announces Closing of 2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
04/11/2024
6
VBI Vaccines FY Non-GAAP EPS of 3.96
04/16/2024
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:
Check out VBI Vaccines Hype Analysis, VBI Vaccines Correlation and VBI Vaccines Performance.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for VBI Stock analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.03)
Revenue Per Share
0.558
Quarterly Revenue Growth
1.911
Return On Assets
(0.29)
Return On Equity
(2.59)
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.